logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence | Journal Article / Research | MSF Science Portal
Journal Article
|Research

Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence

Ritmeijer KKD, ter Horst R, Chane S, Aderie EM, Piening T, Collin SM, Davidson RN
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
Due to unacceptably high mortality with pentavalent antimonials, Médecins Sans Frontières in 2006 began using liposomal amphotericin B (AmBisome) for visceral leishmaniasis (VL) patients in Ethiopia who were severely ill or positive for human immunodeficiency virus (HIV).

Countries

Ethiopia

Subject Area

neglected tropical diseaseskala azarHIV/AIDS

Languages

English
DOI
10.1093/cid/cir674
Published Date
19 Oct 2011
PubMed ID
22016502
Journal
Clinical Infectious Diseases
Volume | Issue | Pages
Volume 53, Issue 12
Issue Date
2011-10-19
Dimensions Badge